Fingerprint
Dive into the research topics of 'Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically